References – How Much Probiotics For Yeast Infection
Forty-two wholesome girls had been randomized to obtain one in all three encapsulated Lactobacillus rhamnosus GR-1 plus Lactobacillus fermentum RC-14 probiotic dosage regimens or L. rhamnosus GG by mouth every day for 28 days. Nevertheless, the vaginal flora, assessed by Nugent scoring, was solely regular in 40% of the circumstances, and 14 sufferers had asymptomatic bacterial vaginosis. Remedy with L. rhamnosus GR-1/L. fermentum RC-14 as soon as and twice day by day correlated with a wholesome vaginal flora in as much as 90% of sufferers, and seven/11 sufferers with bacterial vaginosis transformed to regular or intermediate scores inside 1 month. Ingestion of L. rhamnosus GG did not have an impact. This research confirms the potential efficacy of orally administered lactobacilli as a non-chemotherapeutic means to revive and keep a standard urogenital flora, and exhibits that over 108 viable organisms per day is the required dose.
1 Introduction
Latest research have emphasised the significance of a wholesome, lactobacilli dominated flora not solely to forestall sexually transmitted illnesses [1] and preterm labour [2], but additionally to keep up the standard of life of ladies [3]. In an try and develop a non-chemotherapeutic means to revive and keep a wholesome urogenital tract, probiotic remedy utilizing lactobacilli has been thought of, and there may be proof to point that sure strains may be efficient when inserted immediately into the vagina or when ascending from the rectum after oral ingestion [4–6]. Two strains, Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14, look like notably adept on the latter [6]. Repeated consumption of probiotics could possibly be necessary not solely in girls liable to urogenital infections, but additionally for wholesome girls as their vaginal flora is commonly depleted of lactobacilli thereby rising the chance of an infection [7,8].
The current research was designed to find out the dose required for probiotic lactobacilli to impression the vaginal flora, and to check a industrial product with strains GR-1 and RC-14. A Gram stain system, confirmed to be efficient in assessing the normality or ‘health’ of the vaginal flora with out the necessity for tradition [9], was used. L. rhamnosus GG was chosen as a management arm of the research, as a result of its ingestion fails to have an effect on the vaginal flora [10].
2 Strategies
2.1 Lactobacillus strains
Strains L. rhamnosus GR-1 and L. fermentum RC-14 had been grown in MRS broth (Sigma, Detroit, MI, USA), examined for purity, and freeze dried in equal quantities into gelatin capsules in dosage types of 8×108 and 6×109 viable organisms. Commercially accessible capsules containing 1010 viable L. rhamnosus GG had been bought. All capsules had been positioned in vials and saved in a family fridge till use. Viable counts had been carried out at common intervals to find out shelf life, and no important lack of viability was discovered throughout the period of the research.
2.2 Topics and randomization
The themes, primarily Caucasian, had been recruited by household practices in London, ON, Canada. Every topic voluntarily signed an knowledgeable consent utilizing a format authorised by the Ethics Evaluation Board of the College of Western Ontario. The inclusion standards had been for wholesome girls, 17 years and over (precise vary was 17–50 with imply of 31±8), who had been at present free from urogenital infections (urinary tract an infection (UTI), bacterial vaginosis (BV), or yeast vaginitis) and weren’t on long run, low dose antibiotics for UTI. The exclusion standards had been sufferers with irregular renal perform (serum creatinine >110 µmol l−1, higher restrict 90 µmol l−1) or pyelonephritis, girls who had been pregnant, girls who had been lactose illiberal or receiving prednisone, immunosuppressive medicine, antimicrobial remedy or had been utilizing nonoxynol-9 as a spermicide agent. No topic obtained antibiotics throughout the research.
The capsules had been allotted in a randomized method into vials containing one capsule per day of 1010 of GG (Group 4), 8×108 (Group 1) and 6×109 (Group 3) of GR-1/RC-14, and two per day of the 8×108=1.6×109 (Group 2) GR-1/RC-14 dose. Remedy was given for 28 days. The technician evaluating the Nugent scores was blinded as to the therapies given, as had been the researchers and sufferers, apart from these topics given twice day by day remedy.
2.3 Pattern processing
Deep vaginal swabs had been collected inside 2 days prior to review, then on days 7, 14, 21, 28, 35, and 41. The swabs had been positioned onto glass slides and examined utilizing the Nugent scale (0–3 regular; 4–6 intermediate; 7–10 BV) [9].
3 Outcomes
Compliance was wonderful and all 42 topics accomplished the research, though 4 didn’t present a closing vaginal swab. Not one of the sufferers reported symptomatic yeast vaginitis, UTI or BV or antagonistic unwanted effects throughout the 6 week take a look at interval. Whereas all the topics reported feeling regular with respect to the urogenital tract upon entry into the research, solely 17/42 (40%) really confirmed a standard Nugent rating. Certainly, asymptomatic BV was identified by Nugent scoring in 4/10 girls in Group 1, 3/12 in Group 2, 4/11 in Group 3 and three/9 within the GG management Group 4 (Tables 1–4). BV scores reverted to regular or intermediate at day 28 in 7/11 (64%) topics given one in all three types of GR-1/RC-14 remedy. At 2 week follow-up, 2/9 (22.2%) sufferers within the GG management Group 4 had a BV rating, in comparison with 4/29 (13.8%) within the GR-1/RC-14 handled group (P=0.613 Fisher’s Precise take a look at).
Desk 1 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 104 YV BV BV BV BV BV BV N/A 110 YV/UTI Regular Regular Regular Regular Regular Regular Regular 111 YV Int. Int. Int. Int. Regular Regular Int. 113 UTI Int. Regular Int. Int. Int. BV Int. 116 UTI Regular Regular Regular Regular Regular Regular Regular 117 UTI/YV/BV Regular Regular Int. Regular Regular Regular Regular 118 YV BV Regular Regular Regular Regular Regular Regular 120 YV BV Int. Int. Int. Int. Int. BV 125 YV/UTI Regular Regular Regular Regular Regular Regular Regular 133 None BV BV BV BV BV BV BV Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 104 YV BV BV BV BV BV BV N/A 110 YV/UTI Regular Regular Regular Regular Regular Regular Regular 111 YV Int. Int. Int. Int. Regular Regular Int. 113 UTI Int. Regular Int. Int. Int. BV Int. 116 UTI Regular Regular Regular Regular Regular Regular Regular 117 UTI/YV/BV Regular Regular Int. Regular Regular Regular Regular 118 YV BV Regular Regular Regular Regular Regular Regular 120 YV BV Int. Int. Int. Int. Int. BV 125 YV/UTI Regular Regular Regular Regular Regular Regular Regular 133 None BV BV BV BV BV BV BV Open in new tab
Desk 1 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 104 YV BV BV BV BV BV BV N/A 110 YV/UTI Regular Regular Regular Regular Regular Regular Regular 111 YV Int. Int. Int. Int. Regular Regular Int. 113 UTI Int. Regular Int. Int. Int. BV Int. 116 UTI Regular Regular Regular Regular Regular Regular Regular 117 UTI/YV/BV Regular Regular Int. Regular Regular Regular Regular 118 YV BV Regular Regular Regular Regular Regular Regular 120 YV BV Int. Int. Int. Int. Int. BV 125 YV/UTI Regular Regular Regular Regular Regular Regular Regular 133 None BV BV BV BV BV BV BV Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 104 YV BV BV BV BV BV BV N/A 110 YV/UTI Regular Regular Regular Regular Regular Regular Regular 111 YV Int. Int. Int. Int. Regular Regular Int. 113 UTI Int. Regular Int. Int. Int. BV Int. 116 UTI Regular Regular Regular Regular Regular Regular Regular 117 UTI/YV/BV Regular Regular Int. Regular Regular Regular Regular 118 YV BV Regular Regular Regular Regular Regular Regular 120 YV BV Int. Int. Int. Int. Int. BV 125 YV/UTI Regular Regular Regular Regular Regular Regular Regular 133 None BV BV BV BV BV BV BV Open in new tab
Desk 2 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 101 YV Regular Regular Regular Regular Regular Regular Regular 102 YV Int. Int. Regular Regular Regular Int. Regular 103 UTI Int. Regular Regular Int. Regular Regular Regular 105 YV/UTI BV BV Int. Int. Int. Regular Regular 106 YV/UTI BV BV Int. Regular Regular Regular Regular 107 YV/BV Regular Regular Int. N/A Int. Int. Int. 108 UTI BV BV Int. N/A Int. N/A N/A 109 YV/UTI Regular Regular Regular Regular Regular Regular Regular 121 YV Regular Regular Regular Regular Regular Regular Regular 139 YV Int. Int. Int. Regular Regular Regular Regular 143 BV/YV Regular Regular Int. Regular Regular Regular N/A 145 YV Regular Regular Regular Regular Regular Regular Regular Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 101 YV Regular Regular Regular Regular Regular Regular Regular 102 YV Int. Int. Regular Regular Regular Int. Regular 103 UTI Int. Regular Regular Int. Regular Regular Regular 105 YV/UTI BV BV Int. Int. Int. Regular Regular 106 YV/UTI BV BV Int. Regular Regular Regular Regular 107 YV/BV Regular Regular Int. N/A Int. Int. Int. 108 UTI BV BV Int. N/A Int. N/A N/A 109 YV/UTI Regular Regular Regular Regular Regular Regular Regular 121 YV Regular Regular Regular Regular Regular Regular Regular 139 YV Int. Int. Int. Regular Regular Regular Regular 143 BV/YV Regular Regular Int. Regular Regular Regular N/A 145 YV Regular Regular Regular Regular Regular Regular Regular Open in new tab
Desk 2 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 101 YV Regular Regular Regular Regular Regular Regular Regular 102 YV Int. Int. Regular Regular Regular Int. Regular 103 UTI Int. Regular Regular Int. Regular Regular Regular 105 YV/UTI BV BV Int. Int. Int. Regular Regular 106 YV/UTI BV BV Int. Regular Regular Regular Regular 107 YV/BV Regular Regular Int. N/A Int. Int. Int. 108 UTI BV BV Int. N/A Int. N/A N/A 109 YV/UTI Regular Regular Regular Regular Regular Regular Regular 121 YV Regular Regular Regular Regular Regular Regular Regular 139 YV Int. Int. Int. Regular Regular Regular Regular 143 BV/YV Regular Regular Int. Regular Regular Regular N/A 145 YV Regular Regular Regular Regular Regular Regular Regular Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 101 YV Regular Regular Regular Regular Regular Regular Regular 102 YV Int. Int. Regular Regular Regular Int. Regular 103 UTI Int. Regular Regular Int. Regular Regular Regular 105 YV/UTI BV BV Int. Int. Int. Regular Regular 106 YV/UTI BV BV Int. Regular Regular Regular Regular 107 YV/BV Regular Regular Int. N/A Int. Int. Int. 108 UTI BV BV Int. N/A Int. N/A N/A 109 YV/UTI Regular Regular Regular Regular Regular Regular Regular 121 YV Regular Regular Regular Regular Regular Regular Regular 139 YV Int. Int. Int. Regular Regular Regular Regular 143 BV/YV Regular Regular Int. Regular Regular Regular N/A 145 YV Regular Regular Regular Regular Regular Regular Regular Open in new tab
Desk 3 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 114 UTI/YV Regular Regular Regular Regular Regular Regular Regular 119 UTI/YV Int. Int. Int. Int. Regular Int. Int. 123 YV Regular Regular Regular Regular Regular N/A Regular 124 YV BV BV Int. Int. BV BV BV 126 None Int. BV Int. Int. Int. Int. Int. 127 YV Int. Int. Int. Int. Int. Int. Int. 128 UTI/BV/YV BV BV N/A Int. Regular Int. Int. 129 UTI/BV/YV Regular Regular Regular Regular Regular Regular Int. 130 UTI BV BV BV Int. Int. Int. Regular 131 UV Int. Int. Regular Int. Int. Int. Regular 132 None BV BV BV BV BV BV BV Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 114 UTI/YV Regular Regular Regular Regular Regular Regular Regular 119 UTI/YV Int. Int. Int. Int. Regular Int. Int. 123 YV Regular Regular Regular Regular Regular N/A Regular 124 YV BV BV Int. Int. BV BV BV 126 None Int. BV Int. Int. Int. Int. Int. 127 YV Int. Int. Int. Int. Int. Int. Int. 128 UTI/BV/YV BV BV N/A Int. Regular Int. Int. 129 UTI/BV/YV Regular Regular Regular Regular Regular Regular Int. 130 UTI BV BV BV Int. Int. Int. Regular 131 UV Int. Int. Regular Int. Int. Int. Regular 132 None BV BV BV BV BV BV BV Open in new tab
Desk 3 Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 114 UTI/YV Regular Regular Regular Regular Regular Regular Regular 119 UTI/YV Int. Int. Int. Int. Regular Int. Int. 123 YV Regular Regular Regular Regular Regular N/A Regular 124 YV BV BV Int. Int. BV BV BV 126 None Int. BV Int. Int. Int. Int. Int. 127 YV Int. Int. Int. Int. Int. Int. Int. 128 UTI/BV/YV BV BV N/A Int. Regular Int. Int. 129 UTI/BV/YV Regular Regular Regular Regular Regular Regular Int. 130 UTI BV BV BV Int. Int. Int. Regular 131 UV Int. Int. Regular Int. Int. Int. Regular 132 None BV BV BV BV BV BV BV Affected person No. Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 114 UTI/YV Regular Regular Regular Regular Regular Regular Regular 119 UTI/YV Int. Int. Int. Int. Regular Int. Int. 123 YV Regular Regular Regular Regular Regular N/A Regular 124 YV BV BV Int. Int. BV BV BV 126 None Int. BV Int. Int. Int. Int. Int. 127 YV Int. Int. Int. Int. Int. Int. Int. 128 UTI/BV/YV BV BV N/A Int. Regular Int. Int. 129 UTI/BV/YV Regular Regular Regular Regular Regular Regular Int. 130 UTI BV BV BV Int. Int. Int. Regular 131 UV Int. Int. Regular Int. Int. Int. Regular 132 None BV BV BV BV BV BV BV Open in new tab
Desk 4 Affected person# Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 134 UTI/YV Regular Int. Int. Regular Int. Int. Int. 135 YV BV BV N/A N/A Int. Int. Int. 136 BV/YV Regular Regular Regular Regular Regular Regular Regular 137 UTI/YV Int. Int. Int. Regular Int. Int. BV 138 YV BV BV BV Regular Regular Regular Regular 140 UTI/YV Int. Int. Int. Int. Int. Int. Int. 141 None BV BV BV N/A N/A N/A BV 142 YV/BV Regular Int. Regular Regular Regular Regular Regular 144 YV Regular Regular Regular Int. Int. Int. Int. Affected person# Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 134 UTI/YV Regular Int. Int. Regular Int. Int. Int. 135 YV BV BV N/A N/A Int. Int. Int. 136 BV/YV Regular Regular Regular Regular Regular Regular Regular 137 UTI/YV Int. Int. Int. Regular Int. Int. BV 138 YV BV BV BV Regular Regular Regular Regular 140 UTI/YV Int. Int. Int. Int. Int. Int. Int. 141 None BV BV BV N/A N/A N/A BV 142 YV/BV Regular Int. Regular Regular Regular Regular Regular 144 YV Regular Regular Regular Int. Int. Int. Int. Open in new tab
Desk 4 Affected person# Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 134 UTI/YV Regular Int. Int. Regular Int. Int. Int. 135 YV BV BV N/A N/A Int. Int. Int. 136 BV/YV Regular Regular Regular Regular Regular Regular Regular 137 UTI/YV Int. Int. Int. Regular Int. Int. BV 138 YV BV BV BV Regular Regular Regular Regular 140 UTI/YV Int. Int. Int. Int. Int. Int. Int. 141 None BV BV BV N/A N/A N/A BV 142 YV/BV Regular Int. Regular Regular Regular Regular Regular 144 YV Regular Regular Regular Int. Int. Int. Int. Affected person# Historical past Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 Day 42 134 UTI/YV Regular Int. Int. Regular Int. Int. Int. 135 YV BV BV N/A N/A Int. Int. Int. 136 BV/YV Regular Regular Regular Regular Regular Regular Regular 137 UTI/YV Int. Int. Int. Regular Int. Int. BV 138 YV BV BV BV Regular Regular Regular Regular 140 UTI/YV Int. Int. Int. Int. Int. Int. Int. 141 None BV BV BV N/A N/A N/A BV 142 YV/BV Regular Int. Regular Regular Regular Regular Regular 144 YV Regular Regular Regular Int. Int. Int. Int. Open in new tab
As proven in Desk 4 and summarized in Desk 5, the management GG group confirmed no enchancment within the variety of topics with regular vaginal flora on the finish of 28 days of therapy. Quite the opposite, therapy with the GR-1/RC-14 mixture twice day by day (nonetheless virtually one log lower than one dose of the GG management) resulted in 50% extra regular scores than earlier than therapy began. Inside 2 weeks of completion of therapy, the vaginal flora remained regular (evaluating day 0 and day 28) in 90% of ladies given the twice day by day GR-1/RC-14 lactobacilli, and this was considerably higher than the GG management (P=0.017).
Desk 5 Share of ladies with wholesome vaginal flora Group 1 (8×108) Group 2 (1.6×109) Group 3 (6×109) Group 4 (1010 GG) Earlier than therapy 40 50 27 44 At finish of therapy 60 82 45 38 Two weeks after therapy 56 90 30 33 Share of ladies with wholesome vaginal flora Group 1 (8×108) Group 2 (1.6×109) Group 3 (6×109) Group 4 (1010 GG) Earlier than therapy 40 50 27 44 At finish of therapy 60 82 45 38 Two weeks after therapy 56 90 30 33 Open in new tab
Desk 5 Share of ladies with wholesome vaginal flora Group 1 (8×108) Group 2 (1.6×109) Group 3 (6×109) Group 4 (1010 GG) Earlier than therapy 40 50 27 44 At finish of therapy 60 82 45 38 Two weeks after therapy 56 90 30 33 Share of ladies with wholesome vaginal flora Group 1 (8×108) Group 2 (1.6×109) Group 3 (6×109) Group 4 (1010 GG) Earlier than therapy 40 50 27 44 At finish of therapy 60 82 45 38 Two weeks after therapy 56 90 30 33 Open in new tab
Of the topics who had a historical past of yeast vaginitis throughout the earlier 5 years, 7/13 (54%) who didn’t have a standard flora at entry, developed a standard flora inside 28 days of therapy with GR-1/RC-14, whereas one 1/4 (25%) of the GG controls transformed to regular. Of the 5 topics who had a historical past of BV and offered with a BV Nugent rating, one (No. 128) transformed to a standard flora with GR-1/RC-14 therapy, whereas not one of the GG controls transformed. Of topics with a previous historical past of UTI, therapy with one of many three GR-1/RC-14 doses was higher at changing an irregular flora on day 0 to a standard flora inside 28 days (P=0.043).
The conversion to a standard flora inside 28 days was important for girls in Group 2 (P=0.017), with an inclination in direction of significance for Group 3 (P=0.147), and lack of significance for Group 1 (P=0.611 on day 28; P=0.994 on day 42) in comparison with management Group 4. The dosage kinds increased than 8×108 seemed to be needed for scientific impact.
4 Dialogue
The pool of topics was fairly typical of wholesome girls in a reasonably properly educated, center class neighborhood. Nevertheless, the character of the research attracted extra girls with a historical past of earlier urogenital an infection than in a random inhabitants, and these girls probably characterize shoppers wishing to make the most of useful meals as a method of sustaining well being [11]. The ladies weren’t at excessive threat of sexually transmitted illnesses, in contrast to some populations studied elsewhere [8], resembling these with BV and at higher threat of HIV-1 by sexual activity [12]. Their total historical past of bladder and vaginal an infection was not surprising, given the excessive incidence of those illnesses amongst girls. The low incidence of a historical past of BV was additionally not stunning, given its poor prognosis in neighborhood clinics. The prevalence of regular flora at 40% at first of the research was decrease than the 76.5% reported by Schwebke et al. [8], maybe illustrating the innate abnormality of ladies with a historical past of urogenital infections and antibiotic therapy.
The discovering that the flora was regular within the majority of topics after therapy with lactobacilli strains GR-1 and RC-14, and never the management sufferers taking L. rhamnosus GG, advised strongly that the 2 pressure mixture remedy had an impression on the flora. The ingestion of the GR-1/RC-14 probiotic remedy resulted within the vaginal flora being restored to regular inside 28 days in 82% in a single group of sufferers. That is a lot increased than regular Nugent values reported in a normal wholesome inhabitants of ladies [8]. Whether or not or not an extended period of therapy would imply that the flora could possibly be maintained as regular in all topics stays to be decided. In topics who began with a standard flora, 12/13 (92%) retained normality at day 28 and one scored intermediate following GR-1/RC-14 remedy. That is virtually double the 48% of ladies discovered elsewhere to keep up a standard flora over a menstrual cycle as decided by Nugent scoring [7]. This means that day by day probiotic use could possibly be thought of as a method to keep up a wholesome urogenital flora.
The query of how lengthy on remedy did it take to extend the variety of regular Nugent scores was not an goal of the research, and whereas there is a rise in Teams 1 and a couple of on day 7 and day 21, no assertion of significance may be made.
The dosage kinds didn’t reveal important variations, and it seems that the vary of doses chosen for research was too slim.
There was no important distinction between Group 1 and the management at day 28 or day 42, suggesting {that a} day by day dose higher than 8×108 is required for an impact. The twice day by day dose of GR-1/RC-14 contained significantly fewer organisms than these within the GG management product. The outcomes for L. rhamnosus GG are in line with its incapability to colonize the vagina or defend the host from recurrence of UTI [10].
The prevalence of asymptomatic bacterial vaginosis was 26% (11/42) at research graduation as assessed by Nugent analysis. That is much like the 20% determine present in a bigger research of 635 girls [13]. The conversion of BV scores to regular with GR-1/RC-14 remedy (64%) is increased than the spontaneous conversion fee reported at 12% in a earlier research [14], implying potential scientific significance with probiotic remedy.
For girls liable to recurrence of UTI, GR-1/RC-14 and never GG remedy corresponded with upkeep of a lactobacilli dominated vaginal flora. This reaffirms an earlier discovering that prophylactic antibiotics might in the future get replaced by oral probiotics as a method to forestall UTI [5].
The research was not designed to find out if the ingested strains had been those that colonized the vagina. Quite, even when the impact was a results of the remedy creating an atmosphere higher in a position to assist indigenous lactobacilli development [5], the scientific end result continues to be necessary.
In abstract, the findings point out {that a} day by day oral dose of 108 viable probiotic lactobacilli can restore and keep the urogenital well being of ladies.
Acknowledgements
The help of Ms. D. Lam and Drs. J. Hammond, B. Henning, J. Owen, and E. Smith is way appreciated.
References
[1] van de Wijgert J.H.H.M. Mason P.R. Gwanzura L. 2000 ) Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted illnesses in Zimbabwean girls . J. Infect. Dis. 181 , 587 – 594 . [2] Chaim W. Mazor M. Leiberman J.R. 1997 ) The connection between bacterial vaginosis and preterm start . Arch. Gynecol. Obstet. 259 , 51 – 58 . [3] Ellis A.Okay. Verma S. 2000 ) High quality of life in girls with urinary tract infections: is benign illness a misnomer . J. Am. Board Fam. Pract. 13 , 392 – 397 . [4] Reid G. Bruce A.W. 2001 ) Collection of Lactobacillus strains for urogenital probiotic functions . J. Infect. Dis. 183 ( Suppl. 1 ), S77 – S80 . ), [5] Reid G. Bruce A.W. Taylor M. 1995 ) Instillation of Lactobacillus and stimulation of indigenous organisms to forestall recurrence of urinary tract infections . Microecol. Ther. 23 , 32 – 45 . [6] Reid G. Bruce A.W. Fraser N. Heinemann C. Owen J. Henning B. 2001 ) Oral probiotics can resolve urogenital infections . FEMS Immunol. Med. Microbiol. 30 , 49 – 52 . [7] Keane F.E. Ison C.A. Taylor-Robinson D. 1997 ) A longitudinal research of the vaginal flora over a menstrual cycle . Int. J. STD AIDS 8 , 489 – 494 . [8] Schwebke J.R. Richey C.M. Weiss H.L. 1999 ) Correlation of behaviours with microbiological modifications in vaginal flora . J. Infect. Dis. 180 , 1632 – 1636 . [9] Nugent R.P. Krohn M.A. Hillier S.L. 1991 ) Reliability of diagnosing bacterial vaginosis is improved by a standardization technique of Gram stain interpretation . J. Clin. Microbiol. 29 , 297 – 301 . [10] Kontiokari T. Sundgvist Okay. Nuutinen M. Pokka T. Koskela M. Uhari M. 2001 ) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in girls . Br. Med. J. 522 , 1 – 4 . [11] Childs N.M. 1997 ) The useful meals shoppers: who’re they and what do they need? Implications for product growth and positioning . In: New Applied sciences for Wholesome Meals and Nutraceuticals ( Yalpani M. 313 – 326 . ATL Press , Shrewsbury, MA . . In:, Ed.), pp. [12] Sewankambo N. Grey R.H. Wawer M.J. 1997 ) HIV-1 an infection related to irregular vaginal flora morphology and bacterial vaginosis . Lancet 350 , 530 – 531 . [13] Gratacos E. Figueras F. Barranco M. 1998 ) Spontaneous restoration of bacterial vaginosis throughout being pregnant will not be related to an improved perinatal end result . Acta Obstet. Gynecol. Scand. 77 , 37 – 40 . [14] Hillier S.L. Krohn M.A. Nugent R.P. Gibbs R.S. 1992 ) Traits of three vaginal flora patterns assessed by Gram stain amongst pregnant girls . Am. J. Obstet. Gynecol. 166 , 938 – 944 .
© 2001 Federation of European Microbiological Societies.